Drug Index


Mechanism :

Terbutaline is a beta-adrenergic receptor agonist. Terbutaline exerts a preferential effect on beta 2-adrenergic receptors which are the predominant receptors in bronchial smooth muscle.

Indication :

  • Asthma

Contraindications :

Contraindicated in patients known to be hypersensitive to sympathomimetic amines or any component of this drug product.

Dosing :

<12 years: 0.05 mg/kg 3 times a day. Increase as needed. Max: 5 mg/day.
12-15 years: 2.5 mg 3 times a day. Max: 7.5 mg/day.
>15 years: 5 mg/dose 3 times a day initially, then reduce to 2.5 mg every 6 hours. Max: 15 mg/day.
<12 years: 0.005-0.01 mg/kg (Max: 0.4 mg) every 15-20 mins, for 3 doses. Then every 2-6 hours as needed.
>12 years: 0.25 mg every 15-30 mins for 3 doses as and when needed. Max: 0.5 mg/hour.

Adverse Effect :

Side effects include tremor, headache, nervousness, restlessness, transient hypoglycaemia, dizziness, drowsiness, insomnia, dry mouth, nausea/vomiting, muscle cramps, bad taste, diaphoresis, cardiac arrhythmias, pulmonary edema, myocardial ischemia, tonic cramp, palpitations and hypokalemia.

Interaction :

Monoamine Oxidase Inhibitors or Tricyclic Antidepressants: Terbutaline should be administered with extreme caution to patients being treated with monoamine oxidase inhibitors or tricyclic antidepressants, or within 2 weeks of discontinuation of such agents, since the action of terbutaline on the vascular system may be potentiated.
Beta-Blockers: Beta-adrenergic receptor blocking agents not only block the pulmonary effect of beta-agonists, but may produce severe bronchospasm in asthmatic patients.
Diuretics: The ECG changes and/or hypokalemia that may result from the administration of nonpotassium-sparing diuretics, such as loop or thiazide diuretics, can be acutely worsened by beta-agonists, especially when the recommended dose of the beta-agonist is exceeded.

Renal Dose :

Dose in Renal Impairment GFR (mL/min)
20-5050% of normal parenteral dose. Other routes Dose as in normal renal function
10-2050% of normal parenteral dose. Other routes. Dose as in normal renal function
<10Avoid parenteral dose. Other routes Dose as in normal renal function

Dose in Patients undergoing Renal Replacement Therapies
CAPDLikely dialysability. Dose as in GFR<10 mL/min
HDLikely dialysability. Dose as in GFR<10 mL/min
HDF/High fluxLikely dialysability. Dose as in GFR<10 mL/min
CAV/VVHDLikely dialysability. Dose as in GFR=10–20 mL/min

Hepatic Dose :

No dose adjustment recommended.
01/24/2024 03:48:44 Terbutaline
Disclaimer: The information given by www.pediatriconcall.com is provided by medical and paramedical & Health providers voluntarily for display & is meant only for informational purpose. The site does not guarantee the accuracy or authenticity of the information. Use of any information is solely at the user's own risk. The appearance of advertisement or product information in the various section in the website does not constitute an endorsement or approval by Pediatric Oncall of the quality or value of the said product or of claims made by its manufacturer.
0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0